| GLRBX | HBLTX | GLRBX / HBLTX | |
| Total Expense Ratio | 1.23 | 0.66 | 186% |
| Annual Report Gross Expense Ratio | 1.23 | 0.66 | 186% |
| Fund Existence | 35 years | 16 years | - |
| Gain YTD | 1.879 | 1.774 | 106% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 0 | - |
| Min. Initial Investment IRA | 500 | N/A | - |
| Net Assets | 423M | 11.6B | 4% |
| Annual Yield % from dividends | 1.19 | 3.45 | 35% |
| Returns for 1 year | 11.47 | 8.50 | 135% |
| Returns for 3 years | 31.94 | 16.21 | 197% |
| Returns for 5 years | 19.11 | 11.63 | 164% |
| Returns for 10 years | 18.52 | 56.23 | 33% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYOAX | 59.55 | 0.62 | +1.05% |
| Rydex Biotechnology H | |||
| JGRSX | 12.70 | 0.07 | +0.55% |
| JHancock Global Shareholder Yield R6 | |||
| TRWIX | 25.79 | 0.13 | +0.51% |
| Transamerica International Equity I2 | |||
| AFICX | 94.13 | -0.29 | -0.31% |
| American Funds Fundamental Invs C | |||
| ADGGX | 23.42 | -0.32 | -1.35% |
| American Century Disciplined Growth R5 | |||